Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.13B |
| 2 |
Eaton
ETN
|
+$1.11B |
| 3 |
Analog Devices
ADI
|
+$867M |
| 4 |
Progressive
PGR
|
+$792M |
| 5 |
Datadog
DDOG
|
+$693M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$1.7B |
| 2 |
NVIDIA
NVDA
|
+$1.45B |
| 3 |
Salesforce
CRM
|
+$1.22B |
| 4 |
Advanced Micro Devices
AMD
|
+$1.2B |
| 5 |
lululemon athletica
LULU
|
+$1.11B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 39.74% |
| 2 | Consumer Discretionary | 15.53% |
| 3 | Communication Services | 13.54% |
| 4 | Healthcare | 12.18% |
| 5 | Financials | 8.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
76
Amgen
AMGN
$234B
| $206M | 0.13% |
658,224
+105,710
| +19% | +$31.1M |
|
|
MRSH
77
Marsh
MRSH
$91.9B
| $195M | 0.12% |
924,490
-7,962
| -0.9% | -$1.64M |
|
78
Shift4
FOUR
$3.47B
| $190M | 0.12% |
2,591,882
+228,663
| +10% | +$15.2M |
|
79
Dell
DELL
$295B
| $181M | 0.12% |
1,309,772
+248,490
| +23% | +$33.3M |
|
80
PepsiCo
PEP
$193B
| $180M | 0.12% |
1,094,227
+748,034
| +216% | +$129M |
|
81
ConocoPhillips
COP
$157B
| $179M | 0.11% |
1,561,949
-75,736
| -5% | -$9.2M |
|
82
Cisco
CSCO
$433B
| $161M | 0.1% |
3,397,417
+82,924
| +3% | +$3.94M |
|
83
Kirby Corp
KEX
$7.34B
| $159M | 0.1% |
1,327,882
-73,962
| -5% | -$8.26M |
|
84
Boston Scientific
BSX
$67.9B
| $157M | 0.1% |
2,039,644
+820,324
| +67% | +$60M |
|
85
Freshpet
FRPT
$3.4B
| $153M | 0.1% |
1,186,177
+310,624
| +35% | +$37.3M |
|
86
Truist Financial
TFC
$61.6B
| $151M | 0.1% |
3,886,871
+46,497
| +1% | +$1.76M |
|
87
Performance Food Group
PFGC
$15.8B
| $149M | 0.1% |
2,258,439
-91,275
| -4% | -$6.36M |
|
88
Parker-Hannifin
PH
$125B
| $149M | 0.1% |
294,668
+15,528
| +6% | +$8.33M |
|
89
Gaming and Leisure Properties
GLPI
$12.4B
| $147M | 0.09% |
3,253,827
+49,296
| +2% | +$2.18M |
|
90
Otis Worldwide
OTIS
$27.3B
| $146M | 0.09% |
1,516,365
+144,320
| +11% | +$13.9M |
|
91
Globant
GLOB
$1.75B
| $145M | 0.09% |
816,006
+1,867
| +0.2% | +$329K |
|
92
Procter & Gamble
PG
$334B
| $139M | 0.09% |
841,150
-3,805
| -0.5% | -$622K |
|
|
APLS
93
DELISTED
Apellis Pharmaceuticals
APLS
| $138M | 0.09% |
3,591,416
+350,903
| +11% | +$15.9M |
|
94
Churchill Downs
CHDN
$6.27B
| $137M | 0.09% |
978,179
+130,332
| +15% | +$17.1M |
|
95
Sempra
SRE
$55.1B
| $135M | 0.09% |
1,777,876
-349,319
| -16% | -$25.8M |
|
96
Alexandria Real Estate Equities
ARE
$8.87B
| $130M | 0.08% |
1,108,061
+90,075
| +9% | +$10.7M |
|
97
Southern Company
SO
$102B
| $127M | 0.08% |
1,639,167
-318,603
| -16% | -$24.1M |
|
98
Crinetics Pharmaceuticals
CRNX
$9B
| $125M | 0.08% |
2,780,144
-37,710
| -1% | -$1.74M |
|
99
Weatherford International
WFRD
$6.72B
| $124M | 0.08% |
1,013,842
+48,149
| +5% | +$5.75M |
|
100
East-West Bancorp
EWBC
$17.7B
| $123M | 0.08% |
1,680,912
-6,643
| -0.4% | -$493K |
|
Similar funds
Jennison Associates's Q2 2024 Portfolio in Review
As of Q2 2024, Jennison Associates held 620 positions worth $156B, up 4.3% from $150B the previous quarter. Its ten largest holdings account for 48% of the portfolio.
Jennison Associates's Q2 2024 filing shows 48 new, 288 increased, 229 reduced and 48 closed positions. Its largest new stake was Analog Devices: 4,062,204 shares worth $927M. The largest sale was UnitedHealth, an estimated $1.7B.
By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 39% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Jennison Associates's largest Q2 2024 buy was Analog Devices: 4,062,204 shares worth $927M.
- Jennison Associates added most to Apple in Q2 2024, an estimated $2.13B increase.
- Jennison Associates's biggest Q2 2024 reduction was UnitedHealth, cutting an estimated $1.7B.
- Jennison Associates fully exited Estee Lauder in Q2 2024, selling an estimated $291M.
- Jennison Associates's ten largest holdings make up 48% of its $156B portfolio in Q2 2024.
- Jennison Associates opened 48 new positions and closed 48 in Q2 2024.
- Jennison Associates's portfolio value rose 4.3% quarter-over-quarter to $156B.
Based on Jennison Associates's 13F filing for Q2 2024, filed 5 Aug 2024.